Stocks

February 16, 2024

Biotech Investors Target PHAT Gains

As we’ve been highlighting for a long time, investors and traders continue to seek opportunities in the micro and small-cap healthcare space in hopes of a buyout.

With the most prominent players sitting on tons of cash and needing their next growth driver, it seems like there’s a new company being acquired every day. 🤑

That’s why stocks like Phathom Pharma can rise sharply on seemingly no news. 🤷

Related Articles

Related Articles

Trading Competitions: Week 5 Recap

December 29, 2023

However, investors who prefer a more diversified approach to the biotech sector are finding opportunities in ETFs like XBI. 🧺

Stocktwits user Christopher Brecher shared the chart below showing the S&P Biotech ETF pushing toward the top of a two-year trading range. He points out that a successful breakout through the mid-90s would target the mid-120s over the medium to long term, representing 30% upside.

With the market indexes and healthcare sector ETF $XLV hitting all-time highs, bulls say now is the time for $XBI and other laggards to play catchup. Time will tell if they’re correct, but the healthcare sector and its many industries are a key focus area for investors and traders right now. 🕵️‍♂️

Learn More About...

You Might Also Enjoy

Stocks

March 4, 2024

Semi Stocks Continue To Soar

Semiconductor stocks remain the focus of investors and traders, with Nvidia and Super Micro Computer pushing to all-time highs. The industry is starting the week with several analyst upgrades as Wall Street continues to chase these companies higher. 🌠

Despite the growing concern that the fundamentals may not fully support these short-term surges in price, the path of least resistance remains higher.

Read It

Stocks

December 29, 2023

How The Markets Performed In 2023

As our article about the ultra-wealthy showed, 2023 was a great year for assets (especially the publicly traded ones). Let’s take a quick peek at how things panned out. 👇

First, let’s start with the tech-heavy Nasdaq 100 index. The chart below shows that the index had one of its best rolling 12-month total returns in decades, rising 55%. The actual total return index also hit new all-time monthly closing highs, reiterating that bulls took back the momentum this year in a big way. 🤩

Read It

Stocks

January 24, 2024

Three Tech Stock Milestones

Despite a lackluster close for the major indices, several stocks hit major market-cap milestones. 🤩

First up is Microsoft, which briefly became the second company to cross the $3 trillion market value threshold. Although that didn’t hold into the close, what’s done is done, and the company certainly deserves to be celebrated. Meta’s rebound over the last two years pushed it back above the $1 trillion mark, bringing the total number of companies above this level to eight.

Read It

More in   Stocks

View All

Stocks

December 28, 2023

Stocktwits 2023 Year In Review

What a year it’s been for markets in 2023, with crypto soaring, tech stocks battling back, the economy staying upright, regional banks collapsing, and the Fed setting the stage to cut rates. 

The Stocktwits community was on top of it all, so what better way to recap the year than with some of our platform’s unique data? Let’s dive into it. 👇

Read It

Stocks

March 8, 2024

Stocks Break Their Win Streak

Nvidia’s evil plan to take over the stock market was put on hold today despite labor market data helping build the case for a June rate cut. 🤔

The February jobs report showed that nonfarm payrolls rose by 275,000, topping the 198,000 expected. However, the previous two months’ numbers were revised lower by 167,000 jobs, causing the unemployment rate to jump to 3.90% and signaling a further softening of the labor market. 🔻

Read It

Stocks

December 20, 2023

Stocks Reverse From All-Time Highs

For seemingly no good reason, the stock market experienced its first bout of volatility in several weeks today. The sharp turnaround had some latecomers to the party asking how this could happen to them. As such, it seems like a good time to update our handy S&P 500 roadmap we’ve shared throughout the year. 🗺️

The last time we checked in on this was in early November when stocks found support at a confluence of “technical” levels that many market participants were watching. Since then, it’s been quite the wild ride, with the S&P 500 rallying over 16% in about eight weeks and approaching its all-time highs from 2022.

Read It